Clinical Laboratory Scientist (Contract)
DELFI Diagnostics, Inc.
Summary
In this contract role, you will be responsible for performing high complexity laboratory testing for cancer detection via next generation sequencing. You will work closely with automation, assay development and technology transfer scientists to build scalable infrastructure within the Clinical Laboratory. You will be part of a cross-functional team working to launch products for clinical use.
Job description
What You'll Do
- Perform laboratory tests, procedures, analyses, and reporting of patient results per approved procedures
- Identify and troubleshoot high complexity problems that may adversely affect the test performance
- Perform and document reagent manufacturing and qualification per approved procedures
- Verify instrument performance through inspection, calibration, and maintenance per approved procedures
- Organize and conduct the training of new and existing laboratory personnel on current and new procedures
What You’ll Bring to DELFI
- Must possess an active and valid Clinical Laboratory Scientist (CLS) or Clinical Genetic Molecular Biologist Scientist (CGMBS) license issued by the state of California
- Must fulfill requirements stated in 42 CFR 493.1489 or 493.1491
- Must fulfill requirements stated in the College of American Pathologists Molecular Pathology Checklist
- BS in Biomedical Laboratory Sciences, Clinical Science, or equivalent
- Ability to communicate complex technical results to a cross-functional audience
- Desire to learn about cancer genetics and contribute to a diverse, collaborative and mutually respectful working environment
- 2+ years of Clinical Laboratory experience or equivalent high complexity and volume laboratory experience
- Laboratory experience within the last year
- Experience with next generation sequencing, molecular biology techniques and automated liquid handlers
- Working knowledge of local, state, and federal laboratory regulations
Requirements
- Must possess an active and valid Clinical Laboratory Scientist (CLS) or Clinical Genetic Molecular Biologist Scientist (CGMBS) license issued by the state of California
- Must fulfill requirements stated in 42 CFR 493.1489 or 493.1491
- Must fulfill requirements stated in the College of American Pathologists Molecular Pathology Checklist
- BS in Biomedical Laboratory Sciences, Clinical Science, or equivalent
- Ability to communicate complex technical results to a cross-functional audience
- Desire to learn about cancer genetics and contribute to a diverse, collaborative and mutually respectful working environment
- 2+ years of Clinical Laboratory experience or equivalent high complexity and volume laboratory experience
- Laboratory experience within the last year
- Experience with next generation sequencing, molecular biology techniques and automated liquid handlers
- Working knowledge of local, state, and federal laboratory regulations
Benefits
- 1-2 in-office days per week
Company overview
DELFI Diagnostics, Inc. is a pioneering biotechnology company specializing in liquid biopsy diagnostics for early cancer detection. Founded in 2018 and headquartered in Baltimore, Maryland with additional operations in Palo Alto, California, the company leverages advanced AI, machine learning, and whole genome sequencing technologies to analyze unique patterns of DNA fragmentation in blood samples. DELFI's innovative approach focuses on cell-free DNA (cfDNA) fragmentomics, enabling sensitive detection of cancer through simple blood tests. The company's flagship product, FirstLook Lung, is a laboratory-developed test designed to improve lung cancer screening accessibility and adherence by providing a convenient blood-based alternative to traditional low-dose CT scans. DELFI collaborates with major healthcare systems and research institutions to validate and implement its technology, aiming to address critical gaps in cancer screening and reduce mortality rates through earlier detection. With approximately 51-200 employees and over $330 million in funding, the company represents a significant advancement in precision medicine and cancer diagnostics.